AU2429100A - Peptides of the at1 receptor and their use for preeclampsia and malign hypertension - Google Patents

Peptides of the at1 receptor and their use for preeclampsia and malign hypertension

Info

Publication number
AU2429100A
AU2429100A AU24291/00A AU2429100A AU2429100A AU 2429100 A AU2429100 A AU 2429100A AU 24291/00 A AU24291/00 A AU 24291/00A AU 2429100 A AU2429100 A AU 2429100A AU 2429100 A AU2429100 A AU 2429100A
Authority
AU
Australia
Prior art keywords
preeclampsia
peptides
receptor
malign
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24291/00A
Inventor
Volker Homuth
Friedrich Luft
Gerd Wallukat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Original Assignee
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19954305A external-priority patent/DE19954305A1/en
Application filed by Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Publication of AU2429100A publication Critical patent/AU2429100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU24291/00A 1998-12-24 1999-12-22 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension Abandoned AU2429100A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19860320 1998-12-24
DE19860320 1998-12-24
DE19954305 1999-11-11
DE19954305A DE19954305A1 (en) 1998-12-24 1999-11-11 Peptides of the AT¶1¶ receptor and their use, in particular for the diagnosis of preeclampsia
PCT/DE1999/004112 WO2000039154A2 (en) 1998-12-24 1999-12-22 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension

Publications (1)

Publication Number Publication Date
AU2429100A true AU2429100A (en) 2000-07-31

Family

ID=26051071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24291/00A Abandoned AU2429100A (en) 1998-12-24 1999-12-22 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension

Country Status (5)

Country Link
EP (1) EP1141018A2 (en)
JP (1) JP2002539075A (en)
AU (1) AU2429100A (en)
CA (1) CA2363999A1 (en)
WO (1) WO2000039154A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2314811A1 (en) * 2000-08-02 2002-02-02 Brian Archibald Macvicar Autoimmunity to angiotensin at1 receptors in schizophrenia
DE10123929A1 (en) * 2001-05-11 2002-11-21 Celltrend Gmbh Predicting risk of transplant rejection, by detecting autoantibodies to the AT1 receptor, also immunological test kit
DE10327066A1 (en) * 2002-11-29 2004-09-16 Max-Delbrück-Centrum für Molekulare Medizin Determination of agonistic autoantibodies
EP1570272A2 (en) 2002-11-29 2005-09-07 Max-Delbrück-Centrum Für Molekulare Medizin Identification of agonistic autoantibodies
EP1884775B1 (en) 2006-08-04 2010-01-06 Celltrend GmbH Method for diagnosis of a disease involving an anti-AT1-receptor antibody
EP1884776A1 (en) 2006-08-04 2008-02-06 Celltrend GmbH Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
CN109467599B (en) * 2017-09-08 2021-06-04 武汉华纪元生物技术开发有限公司 Short peptide ATR001, monoclonal antibody prepared from short peptide and having function of preferentially regulating AT1R, and application of monoclonal antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
DE19826442A1 (en) * 1998-06-02 1999-12-09 Affina Immuntechnik Gmbh Rationally designed peptides, their production and their use

Also Published As

Publication number Publication date
JP2002539075A (en) 2002-11-19
WO2000039154A2 (en) 2000-07-06
WO2000039154A3 (en) 2000-09-21
CA2363999A1 (en) 2000-07-06
WO2000039154A8 (en) 2001-02-15
EP1141018A2 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
AU7035398A (en) Compositions and methods for reducing ocular hypertension
AU6868398A (en) Mu-opiate receptor peptides
AU4924396A (en) One trip cement and gravel pack system
AUPO629297A0 (en) Threaded anchor
AU1926000A (en) Pth1r and pth3r receptors
AU5091199A (en) Prion protein and uses thereof
AU6232300A (en) Receptors and associated proteins
AUPP650198A0 (en) Cement formulation
AU4281999A (en) Peptide
AU2429100A (en) Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU8242898A (en) Concrete block, joint for the same, and structure of concrete blocks
AU1242800A (en) Isolated vshk-1 receptor polypeptides and methods of use thereof
AU4768899A (en) Peptide antagonists of the human urokinase receptor and method for selecting them
AU2002360925A1 (en) System for anchoring and securing airships
AU1392800A (en) Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant
AU7449798A (en) Cement grinder
AU1417701A (en) Soluble t cell receptor protein and method of constructing the same
AUPP146698A0 (en) Imbibant grains for bakery and others uses
AU5563699A (en) Analogs of udp-murnac peptides, assays and kits
AU6736598A (en) Methods for selecting cells and their uses
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU5067598A (en) Building crusher and water-supply system for the crusher
AU4986097A (en) Thrombin receptor peptides and uses thereof
AU2001285707A1 (en) Peptides of the alpha1-adrenergic receptor and their use for psoriasis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase